Status: current, Primitive. Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4591202019 | Amivantamab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4591203012 | Amivantamab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Amivantamab | Is a | Enzyme inhibitor protein | true | Inferred relationship | Some | ||
| Amivantamab | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Amivantamab | Is a | Mesenchymal epithelial transition inhibitor | true | Inferred relationship | Some | ||
| Amivantamab | Is a | Epidermal growth factor receptor antagonist | true | Inferred relationship | Some | ||
| Amivantamab | Has disposition | Mesenchymal epithelial transition inhibitor | true | Inferred relationship | Some | ||
| Amivantamab | Has disposition | Epidermal growth factor receptor antagonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Amivantamab-containing product | Has active ingredient | True | Amivantamab | Inferred relationship | Some | 1 |
| Amivantamab only product | Has active ingredient | True | Amivantamab | Inferred relationship | Some | 1 |
| Amivantamab only product in parenteral dose form | Has active ingredient | True | Amivantamab | Inferred relationship | Some | 1 |
| Amivantamab-containing product in parenteral dose form | Has active ingredient | True | Amivantamab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR